在住院癌症患者中评估和治疗缺铁性贫血:可行性研究
Michel Meyers1, Marianne Paesmans2, Wolff Fleur3
1Medical Oncology, Institut Jules Bordet, Brussels, Belgium. michel.meyers@outlook.com.
概括
在入院癌症患者中,静脉注射铁糖 (FCM) 是可行的. 一次剂量有效增加了血红蛋白水平,支持在该人群中进行进一步的临床试验.
科学领域:
- 癌症学
- 血液学
- 临床药理学
背景情况:
- 癌症相关贫血是一种常见的并发症,通常与缺铁有关.
- 静脉注射 (IV) 铁用于门诊患者,但其用于住院癌症患者的研究较少.
- 急性癌症并发症可能会加剧贫血和缺铁.
研究的目的:
- 对住院癌症患者进行静脉注射铁糖 (FCM) 的可行性进行评估.
- 在这个特定的患者群体中描述贫血的病因.
- 评估血红蛋白反应,输血需要以及潜在的预测生物标志物.
主要方法:
- 一项可行性研究涉及铁缺乏症的住院癌症患者.
- 排除血红蛋白< 7 g/ dL,有活性的出血或有禁忌的患者.
- 一次注射1000mg的FCM.
- 评估主要可行性和次要结果,包括血红蛋白水平和输血需求.
主要成果:
- 在55名患者中,有51名患者接受了IVFCM治疗.
- 血红蛋白增加≥1g/ dL在第二周观察到33%,在第四周观察到39%.
- 在28日之前,15%的患者需要输血.
- 没有确定可靠的预测反应生物标志物.
结论:
- 一次静脉注射 FCM 有效提高铁缺乏症住院癌症患者的血红蛋白.
- 这项研究证明了对该群体进行静脉补充铁的可行性.
- 建议进行更大规模的多中心试验,包括生活质量测量.
相关概念视频
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Esophageal Varices-II: Clinical Features and Management
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...


